Our core content on Lung conditions and related factsheets has been translated to a number of other languages.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
European Lung Foundation
Our core content on Lung conditions and related factsheets has been translated to a number of other languages by our volunteer team.
For more languages explore all available Factsheet translations.
Volunteer as a translator or learn how to translate using Chrome, Firefox or Edge browsers.
Home » Study sheds light on how lung cancer spreads in the early stages
A summary of research published in Nature
A new study has revealed some of the processes that happen in the body in the early stages of lung cancer. The research, published in the journal Nature, offers some hope that new drugs could be developed to target this process and slow down or prevent the growth of lung cancer tumours.
Researchers took lung tissue samples and lung tumour samples from 35 people who had surgery to remove parts of the lung with cancer. The researchers then analysed these samples and blood samples from each person in a laboratory. The researchers looked at the lung tissue around the tumour. They did this to understand what happens to the body’s cells as lung cancer takes hold.
By studying the cells in the samples, the researchers could map out a surprising process happening as the tumours grew in the lungs. Immune cells, which normally repair tissue in the body, were being used by tumours when cancer started to grow in the lung. The tumours were able to ‘trick’ the cells into helping them to invade the lung. The process helped tumours to hide from the immune system, that would usually defend the body against disease. The cancer was then able to progress to later stages.
Lung cancer is often diagnosed at a late stage and research efforts have focused on understanding the early stages of lung cancer in the hope of identifying new target areas for treatments. This study helps to build up a picture of what happens in the lung as cancer grows and then spreads. By exploring this, researchers hope that they can understand what drives tumour growth. The processes they discover can then be used as target areas for treatments, such as immunotherapy, which works by supporting our body’s immune system to fight cancer.
Title: Tissue-resident macrophages provide a pro-tumorigenic niche to early NSCLC cells
Sign up to get the latest information and research on lung conditions, hear about our upcoming events and campaigns, plus views from experts and patients! You can unsubscribe at any time.
ELF is a non-profit organisation registered as a UK company (VAT no. GB 115 0027 74) and charity (no. 1118930).
Our Brussels office enterprise number is 0738.383.695
European Lung Foundation's TR ID number in the Transparency Register is: 094039644810-79
| Cookie | Duration | Description |
|---|---|---|
| __Secure-ROLLOUT_TOKEN | 6 months | Description is currently not available. |
| __Secure-YEC | past | Description is currently not available. |
| __Secure-YNID | 6 months | Description is currently not available. |
| Cookie | Duration | Description |
|---|---|---|
| _clck | 1 year | Microsoft Clarity sets this cookie to retain the browser's Clarity User ID and settings exclusive to that website. This guarantees that actions taken during subsequent visits to the same website will be linked to the same user ID. |
| _clsk | 1 day | Microsoft Clarity sets this cookie to store and consolidate a user's pageviews into a single session recording. |
| _ga | 1 year 1 month 4 days | Google Analytics sets this cookie to calculate visitor, session and campaign data and track site usage for the site's analytics report. The cookie stores information anonymously and assigns a randomly generated number to recognise unique visitors. |
| _ga_* | 1 year 1 month 4 days | Google Analytics sets this cookie to store and count page views. |
| CLID | 1 year | Microsoft Clarity set this cookie to store information about how visitors interact with the website. The cookie helps to provide an analysis report. The data collection includes the number of visitors, where they visit the website, and the pages visited. |
| MR | 7 days | This cookie, set by Bing, is used to collect user information for analytics purposes. |
| SM | session | Microsoft Clarity cookie set this cookie for synchronizing the MUID across Microsoft domains. |
| Cookie | Duration | Description |
|---|---|---|
| yt-remote-cast-available | session | The yt-remote-cast-available cookie is used to store the user's preferences regarding whether casting is available on their YouTube video player. |
| yt-remote-cast-installed | session | The yt-remote-cast-installed cookie is used to store the user's video player preferences using embedded YouTube video. |
| yt-remote-connected-devices | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
| yt-remote-device-id | never | YouTube sets this cookie to store the user's video preferences using embedded YouTube videos. |
| yt-remote-fast-check-period | session | The yt-remote-fast-check-period cookie is used by YouTube to store the user's video player preferences for embedded YouTube videos. |
| yt-remote-session-app | session | The yt-remote-session-app cookie is used by YouTube to store user preferences and information about the interface of the embedded YouTube video player. |
| yt-remote-session-name | session | The yt-remote-session-name cookie is used by YouTube to store the user's video player preferences using embedded YouTube video. |
| ytidb::LAST_RESULT_ENTRY_KEY | never | The cookie ytidb::LAST_RESULT_ENTRY_KEY is used by YouTube to store the last search result entry that was clicked by the user. This information is used to improve the user experience by providing more relevant search results in the future. |